About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Philadelphia | 17,591 Studies Near You

Clinical TrialsPhiladelphia

Clinical Trials in Philadelphia

Discover 17,591 clinical trials near Philadelphia, Pennsylvania. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1-20 of 17,591 trials

TerminatedStudy to Evaluate Safety, Pharmacokinetics, and Efficacy of Rociletinib (CO-1686) in Previously Treated Mutant Epidermal Growth Factor Receptor (EGFR) in Non-Small Cell Lung Cancer (NSCLC) PatientsRociletinib is a novel, potent, small molecule irreversible tyrosine kinase inhibitor (TKI) that selectively targets mutant forms of the epidermal growth factor receptor (EGFR)…NCT01526928·Duarte, California and 48 others

Find Trials by Condition in Philadelphia

Breast Cancerin Philadelphia Lung Cancerin Philadelphia Prostate Cancerin Philadelphia Colorectal Cancerin Philadelphia Melanomain Philadelphia Leukemiain Philadelphia Lymphomain Philadelphia Pancreatic Cancerin Philadelphia Ovarian Cancerin Philadelphia Brain Cancerin Philadelphia

Data from ClinicalTrials.govTerms

CompletedA Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular AlterationsPhase 1 and 2 trial to study the safety, pharmacokinetics, pharmacodynamics, patient reported outcomes and efficacy of PF-06463922 in ALK + advanced non-small cell lung cancer…NCT01970865·Fayetteville, Arkansas and 76 others

WithdrawnMucopolysaccharidosis Type II ObservationalThis is an observational study planned to document prospectively disease manifestation and neurocognitive course in pediatric patients with a clinical presentation consistent with…NCT04591834·Oakland, California and 2 others

CompletedAortic Valve Replacement With Trifecta(TM)To confirm the clinical safety and effectiveness of the Trifecta valve.NCT00475709·Los Angeles, California and 17 others

CompletedCentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary BypassThe purpose of the study is to evaluate the safety and effectiveness of the CentriMag ventricular assist system to help patients who have experienced heart failure during surgery…NCT00819793·Phoenix, Arizona and 13 others

CompletedStudy Evaluating Vabicaserin in Subjects With SchizophreniaThe primary purpose of this protocol is to establish the efficacy, safety, and tolerability of vabicaserin (SCA-136) using a once a day capsule in subjects with acute…NCT00563706·Little Rock, Arkansas and 32 others

CompletedEffect of Static vs. Conversational AI-Generated Messages on Colorectal Cancer Screening Intent: a Randomized Controlled TrialThe goal of this clinical trial is to assess whether messages generated by a large language model (LLM), including both static and conversational formats, can increase colorectal…NCT07107152·Philadelphia, Pennsylvania

CompletedEvaluation of WIRION™ EPS in Lower Extremities ArteriesDemonstrate the safety and performance of the WIRION™ EPS in subjects undergoing lower extremity atherectomy for the treatment of Peripheral Arterial Disease (PAD)NCT02780349·Denver, Colorado and 9 others

CompletedA Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer ParticipantsThe purpose of this study is to determine recommended Phase 2 dose (RP2D) regimen(s) of JNJ-75229414 in Part 1 (Dose Escalation and to determine safety at the RP2D regimen(s) in…NCT05022849·Duarte, California and 7 others

CompletedTheory-Based Educational Program for VAP Prevention and Nursing Care in Intensive Care UnitsVentilator-associated pneumonia (VAP) is an important challenge in intensive care and requires nurses to apply evidence-based preventive practices consistently in mechanically…NCT07820826·Amman, Dours

CompletedA Comparison of Study Drug With Placebo and Haloperidol in Patients With SchizophreniaThe purpose of this study is to evaluate the efficacy of the drug SM-13496 compared to a placebo and to haloperidol in patients with schizophrenia.NCT00044044·Birmingham, Alabama and 33 others

CompletedA Pharmacokinetic (PK) and Pharmacodynamic (PD) Dose-ranging Phase II Study of Ticagrelor in Paediatric Patients With Sickle Cell DiseaseThe purpose of this Phase II dose-ranging study is to investigate pharmacokinetic (PK) and pharmacodynamic (PD) properties of various doses of ticagrelor followed by 4 weeks of…NCT02214121·Orange, California and 17 others

CompletedProspective, Multi-Center Clinical Outcomes Study Evaluating the chronOS Strip Combined With Bone Marrow AspirateThe chronOS Strip is a synthetic bone void filler manufactured from chronOS beta-tricalcium phosphate (β-TCP) granules and a resorbable polymer \[poly(lactide co-ε-caprolactone)\].NCT00943384·Birmingham, Alabama and 12 others

RecruitingPhysical Activity in CKDThe goal of this is to test the efficacy of a 12-week physical activity intervention in 64 adolescents with CKD.NCT06624358·Philadelphia, Pennsylvania

CompletedGS 5885 Administered Concomitantly With GS-9451, Tegobuvir and Ribavirin (RBV) in Chronic Genotype 1 Hepatitis C Virus (HCV) InfectionThe purpose of this phase 2 study is to determine whether 30 mg or 90 mg of GS-5885 when given with GS-9451, Tegobuvir and Ribavirin (RBV) for 12 or 24 weeks is effective, safe…NCT01353248·Birmingham, Alabama and 42 others

CompletedPredicting the Safety and Effectiveness of Inferior Vena Cava FiltersPRESERVE is a multi-center, prospective, open-label, non-randomized investigation of commercially available IVC filters from 6 manufacturers placed in subjects for the prevention…NCT02381509·Little Rock, Arkansas and 52 others

WithdrawnPDT Plus Vitamin D3 for Anal DysplasiaThis is a phase I dose escalation study of photodynamic therapy (PDT) for the treatment of patients with pre-malignant tumors and superficial microinvasive disease of the anal…NCT02698293·Philadelphia, Pennsylvania

TerminatedGlobal Non-interventional Heart Failure Disease RegistryThe clinical characteristics, initial presentation, management, and outcomes of patients hospitalized with new-onset (first diagnosis) heart failure (HF) or decompensation of…NCT02595814·San Diego, California and 345 others

CompletedProspective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or NaproxenTo answer the question of overall benefit: risk of celecoxib when compared to two most commonly prescribe traditional (non-selective) nonsteroidal anti-inflammatory drugs (NSAIDs)…NCT00346216·Alabaster, Alabama and 1065 others

UnknownStudy of T900607-Sodium in Chemotherapy Naive Patients With Hepatocellular Carcinoma.The purpose of the study is to determine whether T900607-sodium is effective and safe in treating hepatocellular carcinoma, a type of liver cancer.NCT00043433·La Jolla, California and 11 others

Page 1 of 880Next

Diabetes

in Philadelphia

Heart Diseasein Philadelphia